Mission Statement Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.

Did you miss the Addiction Medicine Review Course in San Francisco? It's not too late to learn from some of the top experts and educators in the field.

MATERIAL TO HELP YOU PASS THE NEW ADDICTION MEDICINE BOARD EXAM.

Interactive Self-Assessment Test and Board Review
NEW! Now includes 7 hours of video from the Board Exam Preparation Track at the 2017 Review Course
15 AMA/PRA Category 1 Credits™ and 7 additional AMA/PRA Category 1 Credits for the newly added 2017 videos.
Pricing: $350
Features an interactive exam preparation with 700 board-style questions as well as 7 ​hours ​of ​video presentations ​which comprised the Certification Exam Preparation Track at the Addiction Medicine Review Course in Anaheim. Also includes the Addiction Medicine Study Guide.

Addiction Medicine Review Course 2017
17 AMA/PRA Cetgory 1 CreditsTM
Pricing: $495
The Addiction Medicine Review Course consists of 18 lectures from the live conference held August 24-27 in San Francisco. Participants will come away with practical knowledge that can be applied to real-world experiences as well as the knowledge needed for the ABMS Addiction Medicine Board Exam.

SPECIAL OFFER (LIMITED TIME). ORDER BOTH COURSES AND SAVE $195.
Regular Price $845, Now $650 - Order HERE

___________________________________

CSAM Takes Part in Federal Grant to Expand Medication Assisted Treatment (MAT) in California

The California Society of Addiction Medicine (CSAM) has been selected by the California Department of Health Care Services (DHCS) to be part of a statewide collaborative project that includes UCLA Integrated Substance Abuse Programs, to increase access to addiction treatment, reduce unmet treatment need, and reduce opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder (OUD).

CSAM will provide training, education, and mentoring to primary care providers as part of this two-year $90 million federal grant under the 21st Century Cures Act that is targeting healthcare in counties and tribal communities that have the highest rates of opioid-related overdose deaths or where treatment resources are inadequate compared to need. The program is being called the “Medication Assisted Treatment (MAT) Expansion Project” and it is focused on populations with limited MAT access including rural areas, American Indian and Native Alaskan tribal communities, and providing access to buprenorphine, a medication used to treat opioid addiction in the privacy of a physician’s office. One part of this project is the selection of 19 treatment programs in counties across the state to receive targeted funding, support for providers, training and other needed resources. CSAM is supporting this part of the project modeled after Vermont’s “Hub and Spoke” system that dramatically increased access to medication assisted treatment (MAT), reduced stigma, and reduced overdose death rates by increasing access to medications used to treat opioid addiction. Vermont now has the highest per capita capacity for treating Opioid Use Disorder (OUD) in the country.

“CSAM is honored to be a coalition partner in this grant and we support the state’s goal of improving access to care for addiction treatment by increasing the number of people receiving treatment by 20,000 over the next two years,” said Jean Marsters, MD, Chair of CSAM’s Committee on Education. “CSAM will help create a foundation for sustainable treatment programs by providing training and mentorship of healthcare providers by addiction medicine specialists, by working to overcome barriers to care, and by updating guidelines that will inform providers on treatment protocols consistent with current State and Federal regulations,” said Marsters. [read more]

Continuing Medical Education

CSAM Webinar Series

CSAM is sponsoring a series of 12 monthly webinars designed to support the implementation of Medication Assisted Treatment (MAT) of opioid use disorders in primary care.  All webinars in the series can be accessed here.

Friday, Oct. 27, 2017 12:00 PDT 
Medication Assisted Treatment for Alcohol Use Disorder | Steven Batki, MD

Previous Video (Recorded 9/22/2017)
Transitioning High-Dose Opioid Chronic Pain Patients to Buprenorphine | Paul Coelho, MD